Cargando…
Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
Autores principales: | Still, Daniel, Do, Kathy, Thompson, Paul, Brackins, Todd, McGrory, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association of Psychiatric Pharmacists
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337883/ https://www.ncbi.nlm.nih.gov/pubmed/37448830 http://dx.doi.org/10.9740/mhc.2023.06.165 |
Ejemplares similares
-
An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use
por: VandenBerg, Amy M.
Publicado: (2022) -
Response to comment on the recently published article “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
por: VandenBerg, Amy M.
Publicado: (2023) -
The known knowns, known unknowns, and unknown unknowns of surveys and sleep
por: Shaker, Marcus, et al.
Publicado: (2022) -
Comment on: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update”
por: Periclou, Antonia, et al.
Publicado: (2019) -
Sepsis-related stress response: known knowns, known unknowns, and unknown unknowns
por: Peng, Jinmin, et al.
Publicado: (2010)